Moneycontrol PRO
HomeNewsTrendsCurrent AffairsOn Day 2 of India's COVID-19 vaccination drive, only 17,000 get their first jab: Here's why

On Day 2 of India's COVID-19 vaccination drive, only 17,000 get their first jab: Here's why

The Health Ministry has informed that a total of 447 cases of adverse event following immunisation have been reported in India over the past two days, out of which only three required hospitalisation.

January 18, 2021 / 07:27 IST

Hardly over 17,000 beneficiaries were vaccinated against the novel coronavirus disease on the second day of the first phase of India's immunisation drive. With a total of 17,072 beneficiaries receiving their first jab on January 17, the total number of people who have received the COVID-19 vaccine in India rose to 2,24,301, the Ministry of Health and Family Welfare said.

On day two of the COVID-19 vaccination programme, only around 17,000 people got vaccinated as against around two lakh on January day one because only six states conducted the immunisation campaign on January 17.

India had recorded the highest day one vaccination number in the world with 207229 healthcare and frontline workers receiving the COVID-19 vaccine shots on January 16.

Speaking about it, the Health Ministry said: "Today being Sunday, only 6 states conducted coronavirus vaccination drive and a total of 17,072 beneficiaries received jabs."

Most states decided to pause the vaccination drive on January 17 because it is a Sunday and the COVID-19 vaccination would have clashed with the immunisation schedules for other illnesses.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Manohar Agnani, Joint Secretary, Health Ministry, explained: “The usual strategy is to avoid days on which there is a holiday or there is routine immunisation for other diseases. Most states are doing it on four days but smaller states like Goa are doing it on two days of the week because they have lesser numbers.”

The Health Ministry also informed that a total of 447 cases of adverse event following immunisation (AEFI) have been reported in India over the past two days. Out of these 447 cases of the vaccine beneficiaries developing adverse symptoms after getting vaccinated, only three required hospitalisation.

Out of the three who had to be hospitalised, only one is still under observation at AIIMS Rishikesh, the other two have been discharged. While one was discharged from the Northern Railway Hospital, Delhi, after 24 hours, the other was discharged from AIIMS Delhi.

Most of the other AEFIs reported so far include minor symptoms like fever, headache, nausea, etc.

Follow our coverage of the coronavirus crisis here

Moneycontrol News
first published: Jan 17, 2021 08:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347